This bi-annual invitational event draws top researchers in the field, and their trainees, from around the globe. The purpose of the meeting is to discuss current research, explore opportunities for new collaborations, and identify the most important needs and priorities for future progress in stem cell, cell therapy, and bioengineering approaches to explore lung biology and/or prevent and treat lung disease.
Although this conference is by invitation only, if you would like to attend, please tell us how you heard about the conference and the name of the lab with which you are associated (or why you would like to attend) so we can pass this information along to the course directors for their consideration. Your inquiry is welcome. Please email the conference assistant: michele.morin@med.uvm.edu.
Due to popular request, we will repeat an expanded hands-on session scheduled during the day on Monday, July 24th designed to provide opportunities for all investigators and trainees to learn up-to-date techniques relevant for lung stem cell, cell therapy, and bioengineering work. Please see Workshop link on the right side toolbar for more information.
Earn academic credit while attending the conference by enrolling in the new UVM Larner College of Medicine course in regenerative medicine. To learn more: CLICK HERE.
Nine Oral Presentation Travel Awards reserved for junior faculty and trainees will be selected through a blinded abstract review process. Trainees applying for a Travel Award, including the women-minority-disabled travel award, should submit a poster abstract by May 1, 2017.
Please use the standard ATS format for abstract presentation. Recommended poster size is 3' x 5'; poster boards and pushpins will be available at the poster session. Thematic poster sessions will happen at specific times during the conference. Please refer to the agenda for specific information. A Sample Abstract is available for review.
John W. Walsh was the creator and leader of several successful businesses when he became a co-founder of the Alpha-1 Foundation in 1995.
He served for more than 20 years as the Foundation's president and CEO, dedicating the rest of his life to seeking new treatments and ultimately a cure for Alpha-1 Antitrypsin Deficiency.He became known as the leading voice internationally for the Alpha-1 community, as a tireless advocate for research, clinical care, and legislation to benefit people with the lung and liver diseases related to Alpha-1.
The pulmonary community mourns his passing.
As a long-term supporter of the Vermont Stem Cell Conference, we are honored to announce a travel scholarship in John's name.Funded by the Alpha-1 Foundation, the travel award will support participation in the conference of a promising young investigator, trainee or junior faculty through a competitive abstract application.
All participants are strongly encouraged to present a poster describing current research. Abstracts must be submitted by June 1, 2017 to be included in the conference booklet.
Two poster awards will be decided based on a competitive scoring process at the conference. These awardees will receive a reimbursement of conference fees.
A new feature of the 2017 conference is a one-minute elevator pitch competition where interested trainees are invited to present a one-minute synopsis of their work. This will be judged during the competition during Session IV on Wednesday, July 26. The trainees with the top two elevator pitches will receive a reimbursement of conference fees.
A variety of lodging is available. Please note that the room blocks sometimes fill quickly; we encourage you to make your reservation as soon as possible to ensure your preferred location. The discounted Sheraton room rates expire on June 30. Please see Lodging link on the right side toolbar for more information.
Please review the "General Participant Information" for further details.
Please CLICK HERE to register for the conference.
Read this article:
Stem Cells Conference - Continuing Medical Education ...
- GeneTether Therapeutics Publishes Paper on Novel Recombination Products in the CFTR Gene - TheNewswire.ca - May 15th, 2022
- Procreating Robots: The Next Big Thing In Cognitive Automation? - Forbes - May 2nd, 2022
- A juicy tomato this summer begins with starting sturdy transplants now. - Vermont Public Radio - April 6th, 2022
- Hard Time: Vermont Hasn't Lost a Single Prisoner to COVID-19. But at What Cost? - Seven Days - March 25th, 2022
- Why the worlds first organic robots are amphibian, African, and smart; By Okezue Bell - SundiataPost - November 22nd, 2021
- The University of Vermont: Impactful research, healthier world - Study International News - July 21st, 2021
- Team Builds the First Living Robots - University of Vermont - June 20th, 2020
- 2019 Stem Cell Conference- Lung Biology, Continuing ... - May 10th, 2020
- Stem Cell therapy Gilman Vermont 05904 - April 16th, 2020
- Scientists Have Created Living Robot Frogs, And They Just May Save Your Life - Parentology - January 28th, 2020
- World's First 'Living Machine' Created Using Frog Cells and Artificial Intelligence - Livescience.com - January 18th, 2020
- Scientists Move Us One Step Closer To A Real-Life Westworld As They Create Robots From Living Cells - BroBible - January 18th, 2020
- US troops were injured in Iran's Jan. 8 attack; Army cancels $45B vehicle competition; Riyadh gives US $0.5B for ops; Navy adding drone controllers to... - January 18th, 2020
- The Democratic Debates Are Downers. That's a Big Problem for All of Us. - Reason - January 18th, 2020
- Stem Cell - Lung Biology | College of Medicine ... - May 13th, 2019
- Women Can Do - Women & Girls in STEM | Women Empowerment - March 6th, 2019
- Stem Cell Therapy Vermont - Cordblood Search Tools - November 13th, 2018
- Stem Cell Centers - Williston > Stem Cell Centers - November 13th, 2018
- Volunteer Scientists in DC-metro schools | Reset Online - June 19th, 2018
- Continuing the debate about right-to-die issues in Appleton - Wichita Eagle - September 6th, 2017
- Year after Jerika Bolen's death, debate continues on right-to-die issues - USA TODAY - August 28th, 2017
- Mark Blazis: Mushroom hunting a delicious endeavor - Worcester Telegram - August 28th, 2017
- Shoulder Stem Cell and Platelet Treatments - Vermont ... - August 23rd, 2017
- S Muoio & Company Has Raised Its Clarcor (CLC) Position; Biolife Solutions (BLFS) Shorts Raised By 7.43% - HuronReport - August 23rd, 2017
- FreshTracks Capital invests in Ogee - vtdigger.org - July 12th, 2017
- Regenexx Stem Cell & Platelet Procedures - Vermont ... - November 23rd, 2016
- Knee Stem Cell Therapy - Vermont Regenerative Medicine - August 6th, 2016
- Home - Vermont Regenerative Medicine - October 19th, 2015
- First Stroke Patient Treated With Neural Stem Cell Therapy - May 20th, 2015
- Developers expect to break ground on NEK biotech plant in May - April 7th, 2015
- Australasian Society for Stem Cell Research The ... - March 7th, 2015
- Stem Cells Cure Blindness | Serendip Studio - January 14th, 2015
- Stem Cell Research Poll Results - iSideWith - November 26th, 2014
- Concise Review: Current Status of Stem Cells and ... - November 5th, 2014
- PROCHYMAL (Human Adult Stem Cells) for the Treatment of ... - October 16th, 2014
- Stem Cell Research | Parkinson's Action Network - September 27th, 2014
- Vermont Stem Cell Treatments | Stem Cell Treatments - September 5th, 2014
- The Vermont Cancer Center's Stem Cell Transplant Program ... - August 24th, 2014